Working with Partners to Support Late-Stage Clinical Trials
Discover how FUJIFILM Biotechnologies collaborates with our partners to accelerate late-stage readiness without compromising quality
In this case study, we delivered a late stage–ready process by generating a new clonal recombinant cell line, tightly controlling post-translational modifications, and maintaining the original phase 1 quality target product profile (QTPP). Leveraging global network expertise and rapid technology transfer we enabled data-driven clone selection and process optimization. Download the infographic to learn more.